Treatment with OA and UA (in MDA-MB231 cells) significantly suppressed mTOR phosphorylation (as shown in Figure 4) and site-specific AKT phosphorylation in a time-dependent manner (shown in Figure 6) in both BrCa cell lines. The gene discussed is AKT1; the disease is invasive breast carcinoma.